New Journey Health Technology Group Co.,LTD (SHE:002219)

Market Cap	8.23B +8.3%
Revenue (ttm)	2.98B -18.3%
Net Income	25.76M -77.0%
EPS	0.01 -77.2%
Shares Out	3.44B
PE Ratio	319.39
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	124,679,146
Average Volume	116,924,982
Open	2.340
Previous Close	2.340
Day's Range	2.330 - 2.390
52-Week Range	2.030 - 2.970
Beta	0.35
RSI	51.73
Earnings Date	Apr 22, 2026

About SHE:002219

New Journey Health Technology Group Co.,LTD, together with its subsidiaries, provides medical services and pharmaceuticals products in China and internationally. The company operates regional medical centers to treat aging diseases, such as tumors, cardiovascular, cerebrovascular, and orthopedics. It is also involved in the research, development, production, and sale of medicines comprising Duyiwei capsules, Ginsengqi Schisandra tablets, Maiping tablets, Prosta Antong tablets, Gongzhongning capsules, Wuhu San, Wei Funing capsules, and other pro...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2001
• Employees: 9,097
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002219

Financial Performance

In 2025, SHE:002219's revenue was 3.05 billion, a decrease of -19.64% compared to the previous year's 3.80 billion. Earnings were 30.94 million, a decrease of -73.04%.